MoneyWorks4Me

Biocon - Quaterly Results

06 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 6245.00 millions grew by 16.27 % from Rs. 5371.00 millions.The Total Profit for the quarter ended June 2026 of Rs. 522.00 millions grew from Rs.-83.00 millionsThe company reported a good operating profit of 1256.00 millions compared to 819.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6245.00 5371.00 16.27 6245.00 5371.00 16.27 23464.00 22426.00 4.63
Other Income 648.00 613.00 5.71 648.00 613.00 5.71 3197.00 2423.00 31.94
PBIDT 1256.00 819.00 53.36 1256.00 819.00 53.36 5458.00 4181.00 30.54
Interest 173.00 562.00 -69.22 173.00 562.00 -69.22 1424.00 2369.00 -39.89
PBDT 1083.00 257.00 321.40 1083.00 257.00 321.40 1883.00 7887.00 -76.13
Depreciation 384.00 333.00 15.32 384.00 333.00 15.32 1373.00 1278.00 7.43
PBT 699.00 -76.00 -1019.74 699.00 -76.00 -1019.74 510.00 6609.00 -92.28
TAX 177.00 7.00 2428.57 177.00 7.00 2428.57 138.00 516.00 -73.26
Deferred Tax 10.00 -4.00 -350.00 10.00 -4.00 -350.00 18.00 11.00 63.64
PAT 522.00 -83.00 -728.92 522.00 -83.00 -728.92 372.00 6093.00 -93.89
Equity 8148.00 6685.00 21.88 8148.00 6685.00 21.88 8105.00 6003.00 35.02
PBIDTM(%) 20.11 15.25 31.89 20.11 15.25 31.89 23.26 18.64 24.77
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..